Study Presents Drug Candidate for Reversing Mucosal Barrier Damage by HIV
Research in preclinical models suggests that recombinant molecule could act as a topical anti-HIV microbicide. A vaginal microbicide that could prevent sexual transmission of HIV-1 in women has tremendous potential for saving lives and helping staunch an epidemic. But the…